BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20557446)

  • 21. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs.
    Messenger KM; Papich MG; Blikslager AT
    J Vet Pharmacol Ther; 2012 Oct; 35(5):452-9. PubMed ID: 21913941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses.
    Parra-Sanchez A; Lugo J; Boothe DM; Gaughan EM; Hanson RR; Duran S; Belknap JK
    Am J Vet Res; 2006 Oct; 67(10):1687-95. PubMed ID: 17014317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of difloxacin and its concentration in body fluids and endometrial tissues of mares after repeated intragastric administration.
    Adams AR; Haines GR; Brown MP; Gronwall R; Merritt K
    Can J Vet Res; 2005 Jul; 69(3):229-35. PubMed ID: 16187554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular penetration of intravenously administered enrofloxacin in the horse.
    Divers TJ; Irby NL; Mohammed HO; Schwark WS
    Equine Vet J; 2008 Mar; 40(2):167-70. PubMed ID: 18089468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
    Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
    Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses.
    Orsini JA; Moate PJ; Engiles J; Norman T; Poppenga R; Benson CE; Boston RC
    J Vet Pharmacol Ther; 2004 Oct; 27(5):293-8. PubMed ID: 15500566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of fluoroquinolone residual levels in chicken eggs by microbiological assay and confirmation by liquid chromatography.
    Cho HJ; Abd El-Aty AM; Goudah A; Sung GM; Yi H; Seo DC; Kim JS; Shim JH; Jeong JY; Lee SH; Shin HC
    Biomed Chromatogr; 2008 Jan; 22(1):92-9. PubMed ID: 17705139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
    Bidgood TL; Papich MG
    J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
    Boothe DM; Boeckh A; Simpson RB; Dubose K
    J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Albert A; Delporte JP; Gustin P
    J Vet Pharmacol Ther; 2010 Apr; 33(2):183-8. PubMed ID: 20444043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic behavior of enrofloxacin and its metabolite ciprofloxacin in urutu pit vipers (Bothrops alternatus) after intramuscular administration.
    Waxman S; Prados AP; de Lucas JJ; San Andrés MI; Regner P; de Oliveira VC; de Roodt A; Rodríguez C
    J Zoo Wildl Med; 2014 Mar; 45(1):78-85. PubMed ID: 24712165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
    Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S; Sweeney RW; Bélanger M
    Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits.
    Elmas M; Yazar E; Uney K; Er Karabacak A
    J Vet Med A Physiol Pathol Clin Med; 2006 Oct; 53(8):410-4. PubMed ID: 16970630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the selection of antimicrobial resistance in fecal Escherichia coli during enrofloxacin administration with a local drug delivery system or with intramuscular injections in a swine model.
    Béraud R; Huneault L; Bernier D; Beaudry F; Letellier A; del Castillo JR
    Can J Vet Res; 2008 Jul; 72(4):311-9. PubMed ID: 18783019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of oral treatment with N-acetylcysteine on the viscosity of intrauterine mucus and endometrial function in estrous mares.
    Witte TS; Melkus E; Walter I; Senge B; Schwab S; Aurich C; Heuwieser W
    Theriogenology; 2012 Oct; 78(6):1199-208. PubMed ID: 22819282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of dexamethasone administered to mares at breeding time in the modulation of persistent mating induced endometritis.
    Bucca S; Carli A; Buckley T; Dolci G; Fogarty U
    Theriogenology; 2008 Oct; 70(7):1093-100. PubMed ID: 18649933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.